These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 3774588)
1. Neuropeptide Y immunoreactivity in human cerebrospinal fluid. Berrettini WH; Nurnberger JI; DiMaggio DA Peptides; 1986; 7(3):455-8. PubMed ID: 3774588 [TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid (CSF) neuropeptide Y- and somatostatin-like immunoreactivities in man. Maeda K; Yasuda M; Kaneda H; Maeda S; Yamadori A Neuropeptides; 1994 Dec; 27(6):323-32. PubMed ID: 7898640 [TBL] [Abstract][Full Text] [Related]
3. Age-related increase in neuropeptide Y-like immunoreactivity in cerebrospinal fluid in women. Taniguchi S; Yanase T; Kurimoto F; Takayanagi R; Haji M; Kurose S; Nawata H Fukuoka Igaku Zasshi; 1994 Dec; 85(12):361-5. PubMed ID: 7883275 [TBL] [Abstract][Full Text] [Related]
4. Increased neuropeptide Y-like immunoreactivity in cerebrospinal fluid and plasma of human immunodeficiency virus-infected patients: relationship to HIV encephalopathy. Malessa R; Heimbach M; Brockmeyer NH; Hengge U; Rascher W; Michel MC J Neurol Sci; 1996 Mar; 136(1-2):154-8. PubMed ID: 8815163 [TBL] [Abstract][Full Text] [Related]
5. Neuropeptide Y levels in central and peripheral cerebrospinal fluid in patients with intracranial disorders. von Holst H; Rudehill A; Lundberg JM Acta Neurochir (Wien); 1991; 112(3-4):132-5. PubMed ID: 1776515 [TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid neuropeptide Y-like immunoreactivity correlates with impulsive aggression in human subjects. Coccaro EF; Lee R; Liu T; Mathé AA Biol Psychiatry; 2012 Dec; 72(12):997-1003. PubMed ID: 22985695 [TBL] [Abstract][Full Text] [Related]
8. Processing of neuropeptide Y and somatostatin in human cerebrospinal fluid as monitored by radioimmunoassay and mass spectrometry. Nilsson C; Westman A; Blennow K; Ekman R Peptides; 1998; 19(7):1137-46. PubMed ID: 9786162 [TBL] [Abstract][Full Text] [Related]
9. Relation of leptin and neuropeptide Y in human blood and cerebrospinal fluid. Dötsch J; Adelmann M; Englaro P; Dötsch A; Hänze J; Blum WF; Kiess W; Rascher W J Neurol Sci; 1997 Oct; 151(2):185-8. PubMed ID: 9349674 [TBL] [Abstract][Full Text] [Related]
10. Excessive release of endogenous neuropeptide Y into cerebrospinal fluid after treatment of spontaneous subarachnoid haemorrhage and its possible impact on self-reported neuropsychological performance - results of a prospective clinical pilot study on good-grade patients. Bründl E; Proescholdt M; Schödel P; Bele S; Höhne J; Zeman F; Stoerr EM; Brawanski A; Schebesch KM Neurol Res; 2018 Dec; 40(12):1001-1013. PubMed ID: 30213237 [TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid neuropeptide Y levels in major depression and reported childhood trauma. Soleimani L; Oquendo MA; Sullivan GM; Mathé AA; Mann JJ Int J Neuropsychopharmacol; 2014 Oct; 18(1):. PubMed ID: 25539507 [TBL] [Abstract][Full Text] [Related]
12. Low neuropeptide Y in cerebrospinal fluid in bipolar patients is associated with previous and prospective suicide attempts. Sandberg JV; Jakobsson J; Pålsson E; Landén M; Mathé AA Eur Neuropsychopharmacol; 2014 Dec; 24(12):1907-15. PubMed ID: 25453484 [TBL] [Abstract][Full Text] [Related]
13. Neuropeptide Y (NPY) in cerebrospinal fluid from patients with Huntington's Disease: increased NPY levels and differential degradation of the NPY1-30 fragment. Wagner L; Björkqvist M; Lundh SH; Wolf R; Börgel A; Schlenzig D; Ludwig HH; Rahfeld JU; Leavitt B; Demuth HU; Petersén Å; von Hörsten S J Neurochem; 2016 Jun; 137(5):820-37. PubMed ID: 27016395 [TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid concentrations of neuropeptide Y in depressed patients and in controls. Gjerris A; Widerlöv E; Werdelin L; Ekman R J Psychiatry Neurosci; 1992 Mar; 17(1):23-7. PubMed ID: 1349825 [TBL] [Abstract][Full Text] [Related]
15. Neuropeptide Y - an early biomarker for cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Schebesch KM; Brawanski A; Bele S; Schödel P; Herbst A; Bründl E; Kagerbauer SM; Martin J; Lohmeier A; Stoerr EM; Proescholdt M Neurol Res; 2013 Dec; 35(10):1038-43. PubMed ID: 23915659 [TBL] [Abstract][Full Text] [Related]
16. [Determination of neuropeptide Y concentration in the cerebrospinal fluid in patients with cerebrovascular diseases and its significance]. Cao XH; Kang DX; Yang LH Zhonghua Nei Ke Za Zhi; 1991 Jul; 30(7):429-30, 457. PubMed ID: 1752158 [TBL] [Abstract][Full Text] [Related]
17. High levels of NPY in rabbit cerebrospinal fluid and immunohistochemical analysis of possible sources. McDonald JK; Han C; Noe BD; Abel PW Brain Res; 1988 Nov; 463(2):259-67. PubMed ID: 3196917 [TBL] [Abstract][Full Text] [Related]
18. Correlation between clinical characteristics and cerebrospinal fluid neuropeptide Y levels in dementia of the Alzheimer type and frontotemporal dementia. Minthon L; Edvinsson L; Gustafson L Alzheimer Dis Assoc Disord; 1996; 10(4):197-203. PubMed ID: 8939279 [TBL] [Abstract][Full Text] [Related]
19. Neuropeptide Y-like immunoreactivity in schizophrenia. Relationships with clinical measures. Peters J; Van Kammen DP; Gelernter J; Yao J; Shaw D Schizophr Res; 1990; 3(5-6):287-94. PubMed ID: 2178001 [TBL] [Abstract][Full Text] [Related]
20. Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: preliminary evidence for association with preproNPY gene polymorphism. Heilig M; Zachrisson O; Thorsell A; Ehnvall A; Mottagui-Tabar S; Sjögren M; Asberg M; Ekman R; Wahlestedt C; Agren H J Psychiatr Res; 2004; 38(2):113-21. PubMed ID: 14757324 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]